NCT01873729View on ClinicalTrials.gov

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Naltrexone

Adults with ADHD

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01873729 - An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. | Biotech Hunter | Biotech Hunter